Skip to ContentSkip to Navigation
How to find us drs. J.C. Beusekamp


Effects of sodium-glucose co-transporter 2 inhibition with empagliflozin on potassium handling in patients with acute heart failure

Effects of empagliflozin on renal sodium and glucose handling in patients with acute heart failure

Randomized, double-blind, placebo-controlled, multicentre pilot study on the effects of empagliflozin on clinical outcomes in patients with acute decompensated heart failure (EMPA-RESPONSE-AHF)

Hyperkalemia and Treatment With RAAS Inhibitors During Acute Heart Failure Hospitalizations and Their Association With Mortality

Potassium abnormalities in patients with heart failure from 11 Asian regions: insights from the ASIAN-HF registry

Potassium and the use of renin-angiotensin-aldosterone system inhibitors in heart failure with reduced ejection fraction: data from BIOSTAT-CHF

Read more